The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS
Open accessAbstract
Several processes take place during an attack of demyelination in multiple sclerosis (MS). The timing of these various processes, and thus of the attack in its entirety, is important if therapeutic stratagies are to be planned. Attempts have been made to introduce and investigate variables relevant to timing the disease processes, leading to staging systems for MS. Here, the terminology and the various parameters used are reviewed, including inflammatory cells, glial cells, axonal loss and myelin staining; then the different systems are compared, including the system put forward by Bö and Trapp, our own modification of that, the Brück and Lassmann system and the recent consensus reached at a Vienna meeting. It is concluded that an ideal staging system does not yet exist, and that, more than anything else, the material dictates the choice for a staging system. The terminology of the Vienna consensus could be used as a reference to facilitate international comparison.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 763
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Selmaj, K., Raine, C. S., Cannella, B., & Brosnan, C. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115102 · Cited by 738
van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J. B., Bertelsmann, F. W., von Blomberg, B. M. E., Woody, J. N., Hartung, H.-P., & Polman, C. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1531 · Cited by 733
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
van Walderveen, M. A. A., Kamphorst, W., Scheltens, P., van Waesberghe, J. H. T. M., Ravid, R., Valk, J., Polman, C. H., & Barkhof, F. (1998) · Neurology · doi:10.1212/wnl.50.5.1282 · Cited by 656
Monocyte/macrophage differentiation in early multiple sclerosis lesions
Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmarch, H. A., & Lassmann, H. (1995) · Annals of Neurology · doi:10.1002/ana.410380514 · Cited by 530
Brück, W., Bitsch, A., Kolenda, H., Brück, Y., Stiefel, M., & Lassmann, H. (1997) · Annals of Neurology · doi:10.1002/ana.410420515 · Cited by 519
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Remyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
Simpson, J. E., Newcombe, J., Cuzner, M. L., & Woodroofe, M. N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00208-7 · Cited by 408
Patterns of oligodendroglia pathology in multiple sclerosis
Ozawa, K., Suchanek, G., Breitschopf, H., Br€ck, W., Budka, H., Jellinger, K., & Lassmann, H. (1994) · Brain · doi:10.1093/brain/117.6.1311 · Cited by 404
Sobel, R. A., Mitchell, M. E., & Fondren, G. (1990) · Europe PMC (PubMed Central) · Cited by 388
Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
Prineas, J. W., Kwon, E. E., Goldenberg, P. Z., Ilyas, A. A., Quarles, R. H., Benjamins, J. A., & Sprinkle, T. J. (1989) · PubMed · Cited by 265
Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
Raine, C. S., Scheinberg, L. C., & Waltz, J. M. (1981) · PubMed · Cited by 264
The longstanding MS lesion. A quantitative MRI and electron microscopic study
BARNES, D., MUNRO, P. M. G., YOUL, B. D., PRINEAS, J. W., & MCDONALD, W. I. (1991) · Brain · doi:10.1093/brain/114.3.1271 · Cited by 256
Bö, L., Mörk, S., Kong, P. A., Nyland, H., Pardo, C. A., & Trapp, B. D. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90075-2 · Cited by 256
Lassmann, H., Raine, C. S., Antel, J., & Prineas, J. W. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00031-9 · Cited by 250
Kockx, M. M., Muhring, J., Knaapen, M., & Meyer, G. R. Y. D. (1998) · Europe PMC (PubMed Central) · Cited by 226
Oligodendrocytes in the early course of multiple sclerosis
Brück, W., Schmied, M., Suchanek, G., Brück, Y., Breitschopf, H., Poser, S., Piddlesden, S., & Lassmann, H. (1994) · Annals of Neurology · doi:10.1002/ana.410350111 · Cited by 216
Bonetti, B., & Raine, C. S. (1997) · Annals of Neurology · doi:10.1002/ana.410420113 · Cited by 207
Brosnan, C. F., Cannella, B., Battistini, L., & Raine, C. S. (1995) · Neurology · doi:10.1212/wnl.45.6_suppl_6.s16 · Cited by 203
Bhardwaj, R. S., Zotz, C., Roth, J., Goebeler, M., Mahnke, K., Falk, M., Meinardus‐Hager, G., Sorg, C., & Zwadlo‐Klarwasser, G. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220732 · Cited by 185
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions
Cossins, J. A., Clements, J. M., Ford, J., Miller, K. M., Pigott, R., Vos, W., Van Der Valk, P., & De Groot, C. J. A. (1997) · Acta Neuropathologica · doi:10.1007/s004010050754 · Cited by 176
Self-citationMultiple sclerosis: relevance of Class I and Class II MHC-expressing cells to lesion development
Traugott, U. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90082-8 · Cited by 171
Washington, R., Burton, J., Todd, R. F., Newman, W., Dragovic, L., & Dore‐Duffy, P. (1994) · Annals of Neurology · doi:10.1002/ana.410350114 · Cited by 167
Ulvestad, E., Williams, K. C., Matre, R., Nyland, H., Olivier, A., & Antel, J. P. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199401000-00004 · Cited by 137
Fibronectin in multiple sclerosis lesions.
Sobel, R. A., & Mitchell, M. E. (1989) · PubMed Central · Cited by 131
Groot, C. J. A. D., Montagne, L., Barten, A. D., Sminia, P., & van der Valk, P. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199902000-00007 · Cited by 128
Ulvestad, E., Williams, K. C., Mørk, S. J., Antel, J. P., & Nyland, H. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00008 · Cited by 126
Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions
Prineas, J. W., & Raine, C. S. (1976) · Neurology · doi:10.1212/wnl.26.6_part_2.29 · Cited by 112
Fundamental Problems in the Pathology of Multiple Sclerosis and Allied Demyelinating Diseases
LUMSDEN, C. E. (1951) · BMJ · doi:10.1136/bmj.1.4714.1035 · Cited by 78
The 150th anniversary of the first depiction of the lesions of multiple sclerosis.
Compston, A. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.10.1249 · Cited by 77
Adams, C. W. M., & Poston, R. N. (1990) · Acta Neuropathologica · doi:10.1007/bf00308926 · Cited by 34
A Colour Atlas of Multiple Sclerosis and Other Myelin Disorders
Weller, R. O. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.10.1216-a · Cited by 34
Microglia Express MHC Class II in Normal and Demyelinating Human White Matter
Hayes, G. M., Woodroofe, M. N., & Cuzner, M. L. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb27150.x · Cited by 10
Sperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Cited by
Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water
Song, S.-K., Sun, S.-W., Ramsbottom, M. J., Chang, C., Russell, J., & Cross, A. H. (2002) · NeuroImage · doi:10.1006/nimg.2002.1267 · Cited by 2,582
Song, S.-K., Sun, S.-W., Ju, W.-K., Lin, S.-J., Cross, A. H., & Neufeld, A. H. (2003) · NeuroImage · doi:10.1016/j.neuroimage.2003.07.005 · Cited by 1,738
Demyelination increases radial diffusivity in corpus callosum of mouse brain
Song, S.-K., Yoshino, J., Le, T. Q., Lin, S.-J., Sun, S.-W., Cross, A. H., & Armstrong, R. C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.01.028 · Cited by 1,658
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain
Schmierer, K., Scaravilli, F., Altmann, D. R., Barker, G. J., & Miller, D. H. (2004) · Annals of Neurology · doi:10.1002/ana.20202 · Cited by 776
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis
Absinta, M., Maric, D., Gharagozloo, M., Garton, T., Smith, M. D., Jin, J., Fitzgerald, K. C., Song, A., Liu, P., Lin, J.-P., et al. (2021) · Nature · doi:10.1038/s41586-021-03892-7 · Cited by 768
Metadata
- Authors
- Van Der Valk, P., & De Groot, C. J. A.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2000-01
- Volume
- 26
- Issue
- 1
- Pages
- 2-10
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W2136119693
- Cited by
- 306
- References
- 38
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.